Page 50 - GPD-4-3

Gene & Protein in Disease NLRP3 in SCI and CHM

2018;96(6):969-977. doi: 10.1016/j.jare.2020.08.004
doi: 10.1002/jnr.24114 44. Lin S, Mei X. Role of NLRP3 inflammasomes in
neuroinflammation diseases. Eur Neurol. 2021;83(6):576-580.
33. Zhong Z, Sanchez-Lopez E, Karin M. Autophagy, NLRP3
inflammasome and auto-inflammatory/immune diseases. doi: 10.1159/000509798
Clin Exp Rheumatol. 2016;34(4 Suppl 98):12-16.
45. Ravindran R, Loebbermann J, Nakaya HI, et al. The amino
34. Mortezaee K, Khanlarkhani N, Beyer C, Zendedel AJ. acid sensor GCN2 controls gut inflammation by inhibiting
Inflammasome: Its role in traumatic brain and spinal cord inflammasome activation. Nature. 2016;531(7595):523-527.
injury. J Cell Physiol. 2018;233(7):5160-5169.
doi: 10.1038/nature17186
doi: 10.1002/jcp.26287
46. Yamamoto S, Yamashina K, Ishikawa M, et al. Protective
35. Curto-Reyes V, Kirschmann G, Pertin M, Drexler SK, and therapeutic role of 2-carba-cyclic phosphatidic acid in
Decosterd I, Suter MR. Neuropathic pain phenotype does demyelinating. J Neuroinflammation. 2017;14:142.
not involve the NLRP3 inflammasome and its end product doi: 10.1186/s12974-017-0923-5
interleukin-1β in the mice spared nerve injury model. PLoS
One. 2015;10(7):e0133707. 47. Baazm M, Behrens V, Beyer C, Nikoubashman O,
Zendedel A. Regulation of inflammasomes by application of
doi: 10.1371/journal.pone.0133707
omega-3 polyunsaturated fatty acids in a spinal cord injury
36. Ramos HJ, Lanteri MC, Blahnik G, et al. IL-1β signaling model. Cells. 2021;10(11):3147.
promotes CNS-intrinsic immune control of West Nile virus doi: 10.3390/cells10113147
infection. PLoS Pathog. 2012;8(11):e1003039.
48. Shiraishi Y, Kimura A, Kimura H, Ohmori T, Takahashi M,
doi: 10.1371/journal.ppat.1003039
Takeshita K. Deletion of inflammasome adaptor protein
37. Compan V, Baroja-Mazo A, López-Castejón G, et al. Cell ASC enhances functional recovery after spinal cord injury
volume regulation modulates NLRP3 inflammasome in mice. J Orthop Sci. 2021;26(3):487-493.
activation. Immunity. 2012;37(3):487-500.
doi: 10.1016/j.jos.2020.04.006
doi: 10.1016/j.immuni.2012.06.013
49. Dick MS, Sborgi L, Rühl S, Hiller S, Broz P. ASC filament
38. Gu G, Yu H, Zou H, et al. Pyroptosis in spinal cord injury: formation serves as a signal amplification mechanism for
Implications for pathogenesis and therapeutic approaches. inflammasomes. Nat Commun. 2016;7(1):11929.
Front Biosci (Landmark Ed). 2024;29(6):210.
doi: 10.1038/ncomms11929
doi: 10.31083/j.fbl2906210
50. Wu D, Zhang Y, Zhao C, et al. Disruption of C/EBPβ-Clec7a
39. Mangan MS, Olhava EJ, Roush WR, Seidel HM, Glick GD, axis exacerbates neuroinflammatory injury via NLRP3
Latz E. Targeting the NLRP3 inflammasome in inflammatory inflammasome-mediated pyroptosis in experimental
diseases. Nat Rev Drug Discov. 2018;17(8):588-606. neuropathic pain. J Transl Med. 2022;20(1):583.
doi: 10.1038/nrd.2018.97 doi: 10.1186/s12967-022-03779-9
40. Seok JK, Kang HC, Cho YY, Lee HS, Lee JY. Regulation of the 51. Rahman SM, Janssen RC, Choudhury M, et al. CCAAT/
NLRP3 inflammasome by post-translational modifications enhancer-binding protein β (C/EBPβ) expression regulates
and small molecules. Front Immunol. 2021;11:618231. dietary-induced inflammation in macrophages and adipose
tissue in mice. J Biol Chem. 2012;287(41):34349-34360.
doi: 10.3389/fimmu.2020.618231
doi: 10.1074/jbc.M112.410613
41. Wilms H, Sievers J, Rickert U, Rostami-Yazdi M, Mrowietz U,
Lucius RJ. Dimethylfumarate inhibits microglial and 52. Liu P, Cheng J, Ma S, Zhou J. Paeoniflorin attenuates
astrocytic inflammation by suppressing the synthesis of chronic constriction injury-induced neuropathic pain
nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of by suppressing spinal NLRP3 inflammasome activation.
brain inflammation. J Neuroinflammation. 2010;7:30. Inflammopharmacology. 2020;28:1495-1508.
doi: 10.1186/1742-2094-7-30 doi: 10.1007/s10787-020-00737-z
42. Guo R, Gao S, Feng Y, Mao C, Sheng W. Ulinastatin 53. Wang YH, Tang YR, Gao X, et al. The anti-inflammatory and
attenuates spinal cord injury by targeting AMPK/NLRP3 analgesic effects of intraperitoneal melatonin after spinal
signaling pathway. J Chem Neuroanat. 2022;125:102145. nerve ligation are mediated by inhibition of the NF-κB/
NLRP3 inflammasome signaling pathway. Brain Res Bull.
doi: 10.1016/j.jchemneu.2022.102145
2021;169:156-166.
43. Al Mamun A, Wu Y, Monalisa I, et al. Role of pyroptosis
in spinal cord injury and its therapeutic implications. J Adv doi: 10.1016/j.brainresbull.2021.01.015
Res. 2021;28:97-109. 54. Zendedel A, Johann S, Mehrabi S, et al. Activation and

Volume 4 Issue 3 (2025) 8 doi: 10.36922/gpd.4827